11-65961961-G-A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The ENST00000312397.10(SART1):c.181G>A(p.Gly61Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000256 in 1,524,628 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
ENST00000312397.10 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SART1 | NM_005146.5 | c.181G>A | p.Gly61Ser | missense_variant | 1/20 | ENST00000312397.10 | NP_005137.1 | |
SART1 | XM_047427856.1 | c.181G>A | p.Gly61Ser | missense_variant | 1/13 | XP_047283812.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SART1 | ENST00000312397.10 | c.181G>A | p.Gly61Ser | missense_variant | 1/20 | 1 | NM_005146.5 | ENSP00000310448 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152186Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000417 AC: 5AN: 119878Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 66012
GnomAD4 exome AF: 0.0000262 AC: 36AN: 1372442Hom.: 0 Cov.: 30 AF XY: 0.0000236 AC XY: 16AN XY: 676966
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152186Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74340
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 12, 2024 | The c.181G>A (p.G61S) alteration is located in exon 1 (coding exon 1) of the SART1 gene. This alteration results from a G to A substitution at nucleotide position 181, causing the glycine (G) at amino acid position 61 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at